Diagnostic and Therapeutic Pathway in Diffuse Malignant Peritoneal Mesothelioma

Diagnostic and Therapeutic Pathway in Diffuse Malignant Peritoneal Mesothelioma

Diffuse malignant peritoneal mesothelioma (DMPM) is a rare form of mesothelioma that carries a very poor prognosis. The 5-year overall survival is about 20% (±5.9). Survival is optimal for patients suitable for cytoreductive surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC), with...

Full description

Bibliographic Details
Main Authors:	Shigeki Kusamura, Dario Baratti, Michele De Simone, Enrico Maria Pasqual, Luca Ansaloni, Daniele Marrelli, Manuela Robella, Fabio Accarpio, Mario Valle, Stefano Scaringi, Daniele Biacchi, Carmen Palopoli, Sergio Gazzanelli, Marcello Guaglio, Marcello Deraco
Format:	Article
Language:	English
Published:	MDPI AG 2023-01-01
Series:	Cancers
Subjects:	diffuse malignant peritoneal mesothelioma cytoreductive surgery HIPEC
Online Access:	https://www.mdpi.com/2072-6694/15/3/662

Similar Items

Peritoneal Mesothelioma in a High Volume Peritoneal Surface Malignancies Unit
by: Fernando Pereira, et al.
Published: (2023-03-01)

Diagnostic and Therapeutic Algorithm for Appendiceal Tumors and Pseudomyxoma Peritonei: A Consensus of the Peritoneal Malignancies Oncoteam of the Italian Society of Surgical Oncology (SICO)
by: Marco Vaira, et al.
Published: (2023-01-01)

Malignant peritoneal mesothelioma without asbestos exposure: An ovarian cancer imitator
by: Kassondra S. Grzankowski, et al.
Published: (2015-01-01)

Malignant Peritoneal Mesothelioma: An In-Depth and Up-to-Date Review of Pathogenesis, Diagnosis, Management and Future Directions
by: Josh B. Karpes, et al.
Published: (2023-09-01)

Complications and Mortality Rate of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: Italian Peritoneal Surface Malignancies Oncoteam Results Analysis
by: Fabio Carboni, et al.
Published: (2022-11-01)

Laparoscopic Cytoreduction Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Peritoneal Surface Malignancies (PSM): Italian PSM Oncoteam Evidence and Literature Review
by: Antonio Sommariva, et al.
Published: (2022-12-01)

Treatment of Patients with Malignant Peritoneal Mesothelioma
by: Claire Y. Li, et al.
Published: (2022-03-01)

Repeated Cytoreduction Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Selected Patients Affected by Peritoneal Metastases: Italian PSM Oncoteam Evidence
by: Enrico Maria Pasqual, et al.
Published: (2023-01-01)

Benign Multi-Cystic Peritoneal Mesothelioma: A Case Report
by: Ali Shaghaghi, et al.
Published: (2019-06-01)

Incidence, Survival Analysis and Future Perspective of Primary Peritoneal Mesothelioma (PPM): A Population-Based Study from SEER Database
by: Asad Ullah, et al.
Published: (2022-02-01)

Molecular Signatures for Combined Targeted Treatments in Diffuse Malignant Peritoneal Mesothelioma
by: Antonino Belfiore, et al.
Published: (2019-11-01)

Enhanced Recovery after Surgery (ERAS) Program for Patients with Peritoneal Surface Malignancies Undergoing Cytoreductive Surgery with or without HIPEC: A Systematic Review and a Meta-Analysis
by: Manuela Robella, et al.
Published: (2023-01-01)

Multicystic peritoneal mesothelioma treated with cytoreductive surgery followed or not by hyperthermic intraperitoneal chemotherapy: results from a large multicentric cohort
by: Vahan Kepenekian, et al.
Published: (2021-01-01)

Colorectal Cancer with Peritoneal Metastases: The Impact of the Results of PROPHYLOCHIP, COLOPEC, and PRODIGE 7 Trials on Peritoneal Disease Management
by: Antonio Sommariva, et al.
Published: (2022-12-01)

Treatment of Peritoneal Surface Malignancies by Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Spain: Results of the National Registry of the Spanish Group of Peritoneal Oncologic Surgery (REGECOP)
by: Israel Manzanedo, et al.
Published: (2023-05-01)

Communicating imaging findings in peritoneal mesothelioma: the impact of ‘PAUSE’ on surgical decision-making
by: Anuradha Chandramohan, et al.
Published: (2021-11-01)

Prolonged Exposition with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) May Provide Survival Benefit after Cytoreductive Surgery (CRS) in Advanced Primary Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
by: Miklos Acs, et al.
Published: (2022-07-01)

Gastric Cancer with Peritoneal Metastases: Current Status and Prospects for Treatment
by: Israel Manzanedo, et al.
Published: (2023-03-01)

Peritoneal mesothelioma in Sweden: A population‐based study
by: Peter H. Cashin, et al.
Published: (2019-10-01)

Desmoid-type fibromatosis in the setting of malignant peritoneal mesothelioma: a case report of two rare diseases
by: Stephanie N. Gregory, et al.
Published: (2022-09-01)

Predictors of Recurrence of Peritoneal Carcinomatosis among Patients with Colorectal Cancer Following Cytoreductive Surgery alone versus Cytoreductive Surgery Plus HIPEC
by: Waheed Yousry Gareer, et al.
Published: (2022-06-01)

Twelve-Year Single Center Experience Shows Safe Implementation of Developed Peritoneal Surface Malignancy Treatment Protocols for Gastrointestinal and Gynecological Primary Tumors
by: Philipp Horvath, et al.
Published: (2021-05-01)

Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Epithelial Ovarian Cancer: A 20-Year Single-Center Experience
by: Fabio Carboni, et al.
Published: (2021-01-01)

Advances in diffuse malignant peritoneal mesothelioma
by: Tristan D. Yan, et al.
Published: (2011-12-01)

Advances in diffuse malignant peritoneal mesothelioma
by: Tristan D. Yan, et al.
Published: (2011-12-01)

HIPEC in Peritoneal Metastasis of Gastric Origin: A Systematic Review of Regimens and Techniques
by: Felix Gronau, et al.
Published: (2022-03-01)

Prognostic factors of malignant peritoneal mesothelioma: a retrospective study of 52 female patients
by: Jianting Ma, et al.
Published: (2022-06-01)

Diffuse malignant peritoneal mesothelioma: A review
by: Luanbiao Sun, et al.
Published: (2023-01-01)

Gastric Cancer (GC) with Peritoneal Metastases (PMs): An Overview of Italian PSM Oncoteam Evidence and Study Purposes
by: Paolo Sammartino, et al.
Published: (2023-06-01)

Cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) vs CRS alone for treatment of endometrial cancer with peritoneal metastases: a multi-institutional study from PSOGI and BIG RENAPE groups
by: Manuel Gomes David, et al.
Published: (2022-01-01)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Summary of Key Clinical Trials
by: Kevin M. Turner, et al.
Published: (2022-06-01)

Therapeutic Strategies and Oncological Outcome of Peritoneal Metastases from Lung Cancer: A Systematic Review and Pooled Analysis
by: Leandro Siragusa, et al.
Published: (2023-03-01)

Neoadjuvant chemotherapy does not improve survival for patients with high volume colorectal peritoneal metastases undergoing cytoreductive surgery
by: Mina Sarofim, et al.
Published: (2024-04-01)

Diffuse malignant peritoneal mesothelioma
by: Chih-An Shih, et al.
Published: (2013-11-01)

Review of Regional Therapies for Gastric Cancer with Peritoneal Metastases
by: Beatrice J. Sun, et al.
Published: (2022-01-01)

Contemporary Trends in Malignant Peritoneal Mesothelioma: Incidence and Survival in the United States
by: Lucia Calthorpe, et al.
Published: (2022-12-01)

Diffuse Peritoneal Malignant Mesothelioma Presenting with Abnormal Uterine Bleeding: Case Report
by: Ivana Rizzuto, et al.
Published: (2022-03-01)

Peritoneal Metastatic Gastric Cancer: Local Treatment Options and Recommendations
by: Miklos Acs, et al.
Published: (2024-03-01)

Durable Response after Repeat Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in a Patient with Extensive Mucinous Adenocarcinoma of the Appendix
by: Dalia Kaakour, et al.
Published: (2023-04-01)

Current Research and Development in Hyperthermic Intraperitoneal Chemotherapy (HIPEC)—A Cross-Sectional Analysis of Clinical Trials Registered on ClinicalTrials.gov
by: Kristjan Ukegjini, et al.
Published: (2023-03-01)